CrushSCI.com
120.6平均天数
124中位天数
63最短天数
252最长天数
6272025发文量

Paper Review Records

全部论文审稿周期

15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

78 天

Real-world ctDNA test utilization and associated costs in US patients with bladder cancer who underwent radical cystectomy

作者
Todd M. Morgan; Ching-Yu Wang; Halit O. Yapici; Jonathan Lilley; Weiqi Jiao; Kunal Lodaya; Haojie Li展开收起
作者单位
Department of Urology, University of Michigan, Ann Arbor, MI; Department of Outcomes Research, Merck & Co. Inc., Rahway, NJ; Department of Health Economics and Outcomes Research, Boston Strategic Partners Inc., Boston, MA展开收起
PDF源文件 DOI 网页
150 天

Serum Galectin-3 as a complementary biomarker in non-muscle-invasive bladder cancer

作者
Recep Eryılmaz; Muhammed Fatih Keleş; Rahmi Aslan; Zübeyir Huyut; Murat Demir; Kasım Ertaş; Mehmet Sevim; Kerem Taken展开收起
作者单位
Department of Urology, Faculty of Medicine, Van Yüzüncü Yıl University, Van, Türkiye; Department of Biochemistry, Faculty of Medicine, Van Yüzüncü Yıl University, Van, Türkiye; Department of Urology, Van Training and Research Hospital, Van, Türkiye; Department of Urology, Akdamar Hospital, Van, Türkiye展开收起
PDF源文件 DOI 网页
252 天

Association of robot-assisted radical prostatectomy with improved oncological outcomes in patients with oligometastatic prostate cancer: A multicenter exploratory study in China

作者
Yujie Dong; Zhen Tian; Weilin Chen; Zhuoran Li; Zhiqiang Chen; Jieping Hu; Bin Fu; Xiaofeng Xu; Xu Zhang; Baojun Wang展开收起
作者单位
Senior Department of Urology, Chinese PLA General Hospital, Beijing, China; Department of Urology, The First Affiliated Hospital, Soochow Medical College, Soochow University, Soochow, Jiangsu, China; Department of Urology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China展开收起
PDF源文件 DOI 网页
155 天

The AURKA–PTTG1 signaling axis induces enzalutamide resistance in prostate cancer

作者
Guangye Han; Zhenhui Li; Weihang Song; Lei Li; Junling Hu展开收起
作者单位
Department of Urology, The First Affiliated Hospital of Henan Medical University, Xinxiang, Henan, China展开收起
PDF源文件 DOI 网页
69 天

Risk of androgen deprivation therapy after active surveillance for prostate cancer: A real-world analysis

作者
James R. Janopaul-Naylor; Dattatraya Patil; Nikhil T. Sebastian; Kamran Salari; Bruce Hershatter; Christopher Gaffney; Martin G. Sanda; Shreyas S. Joshi; Pretesh R. Patel; Ashesh B. Jani; Sagar A. Patel展开收起
作者单位
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Urology, Emory University, Atlanta, GA; Department of Radiation Oncology, Emory University, Atlanta, GA; Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY展开收起
PDF源文件 DOI 网页
165 天

KDM6A suppresses proliferation and epithelial–mesenchymal transition in prostate cancer cells

作者
Yixiu Ni; Yijia Lin; Wankun Wang; Yizhong Bao; Jun Chen展开收起
作者单位
Department of Urology, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China展开收起
PDF源文件 DOI 网页

FAQ

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS审稿要多久?

截至2026-11-19,CrushSCI 收录了 UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 的 15 篇完整审稿记录。最快一篇从收稿到录用用了 63 天(miR-638 Upregulation in Serum and Tissues Functions as a Diagnostic and Prognostic Biomarker and Facilitates Prostate Cancer Progression,2026-05-26 收稿,2026-07-28 录用),最慢一篇用了 252 天;平均 120.6 天,中位数 124 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。